(S1 (S (S (NP (JJ Membrane-anchored) (NN Cbl)) (VP (VBZ suppresses) (NP (NP (NN Hck) (NN protein-tyrosine) (NN kinase)) (JJ mediated) (JJ cellular) (NN transformation)))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ mammalian) (NN proto-oncogene) (NN Cbl)) (CC and) (NP (NP (PRP$ its) (JJ cellular) (NNS homologues)) (PP (IN in) (NP (NP (NP (FW Caenorhabditis) (FW elegans)) (PRN (-LRB- -LRB-) (NP (NN Sli-1)) (-RRB- -RRB-))) (CC and) (NP (NP (FW Drosophila)) (PRN (-LRB- -LRB-) (NP (NN D-Cbl)) (-RRB- -RRB-))))))) (VP (VBP are) (NP (NP (JJ negative) (NNS regulators)) (PP (IN of) (NP (DT some) (NP (NN growth) (NN factor) (NN receptor)) (NN signaling) (NNS pathways)))))) (. .)))
(S1 (S (ADVP (RB Herein)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN Cbl)) (VP (MD can) (ADVP (RB negatively)) (VP (VB regulate) (NP (NP (DT another) (NN signaling) (NN molecule)) (, ,) (NP (ADVP (RB namely)) (NP (NN theSrc-family) (NN kinase) (NN Hck)))) (PP (IN by) (S (VP (VBG targeting) (NP (PRP it)) (PP (IN for) (NP (NN degradation))))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Hck-mediated) (JJ cellular) (NN transformation)) (PP (IN of) (NP (JJ murine) (NNS fibroblasts)))) (VP (VBZ is) (VP (VBD reverted) (PP (IN by) (NP (NP (JJ ectopic) (NN expression)) (PP (IN of) (NP (NP (DT a) (JJ membrane-anchored) (NN allele)) (PP (IN of) (NP (NN Cbl))))))) (SBAR (IN as) (S (VP (VBN assessed) (PP (IN by) (NP (NP (DT the) (JJ cellular) (NN morphology)) (, ,) (NP (NP (NN suppression)) (PP (IN of) (NP (JJ anchorage) (JJ independent) (NN growth)))) (, ,) (CC and) (NP (NP (DT an) (JJ overall) (NN reduction)) (PP (IN in) (NP (NP (DT the) (JJ total) (NN tyrosine) (NN phosphorylation) (NNS levels)) (PP (IN within) (NP (DT the) (NNS cells)))))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NN Cbl))) (PP (IN at) (NP (DT the) (NN plasma) (NN membrane)))) (VP (VBZ targets) (NP (CC both) (NP (NN Hck)) (CC and) (NP (PRP itself))) (PP (IN for) (NP (NP (NN ubiquitination)) (CC and) (NP (NN degradation)))) (, ,) (S (VP (VBG requiring) (NP (DT an) (JJ intact) (NN RING) (NN finger)))))) (. .)))
(S1 (S (S (NP (NP (JJ Pharmacological) (NN inhibition)) (PP (IN of) (NP (DT the) (NN proteasome)))) (VP (VBZ prevents) (NP (NP (DT the) (NN degradation)) (PP (IN of) (NP (NP (NN Hck)) (VP (VBG correlating) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN phosphotyrosine) (NNS levels)) (PP (IN within) (NP (DT the) (NNS cells))))))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Activated) (NN Hck)) (CC and) (NP (JJ membrane-anchored) (NN Cbl))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (NP (JJ similar) (JJ subcellular) (NNS localizations)) (CC and) (NP (NN co-immunoprecipitate))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (PRP$ their) (NN interaction)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (JJ subsequent) (NN ubiquitination)) (CC and) (NP (NN degradation)))))))))))) (. .)))
(S1 (S (S (ADVP (RB Interestingly)) (, ,) (NP (ADJP (CC both) (ADJP (RB constitutively) (JJ active)) (CC and) (ADJP (JJ kinase-inactive))) (NN Hck)) (VP (VP (VBP interact) (PP (IN with))) (CC and) (VP (VBP are) (VP (VBN targeted) (PP (IN for) (NP (NP (NN degradation)) (PP (IN by) (NP (NN Cbl))))))))) (. .)))
(S1 (S (S (NP (DT This) (NN work)) (VP (VP (VBZ illustrates) (NP (NP (JJ alternate) (NN means)) (S (VP (TO to) (VP (VB regulate) (NP (NN Src-family) (NNS kinases))))))) (, ,) (CC and) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN Cbl)) (VP (MD may) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (VP (VB suppress) (NP (NP (JJ many) (NN signaling) (NNS pathways)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN activated) (PP (IN in) (NP (NP (JJ various) (JJ proliferative) (NNS syndromes)) (PP (VBG including) (NP (NN cancer))))))))))))))))))))) (. .)))
